New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
06:49 EDTBDSIBioDelivery Sciences upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded BioDelivery Sciences citing the competitive position of the company's chronic pain treatment BBCP. The firm raised its price target for shares to $8 from $5.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 16, 2015
11:36 EDTBDSIBioDelivery Sciences management to meet with FBR Capital
Meetings to be held in Minneapolis on July 22 and in Dallas on July 23 hosted by FBR Capital.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use